Keratoconus is a progressive corneal disease. The onset is usually late teens or early 20’s but can occur later in life in some individuals. If left untreated keratoconus can lead to progressive vision loss, inability to wear glasses or contact lenses, and possibly corneal transplant surgery. The earlier keratoconus is diagnosed and treated the better the long-term visual outcome.
Often keratoconus patients are informed that wearing contact lenses will stop the disease from progressing. Contact lenses DO NOT hold back the keratoconus from progressing. Waiting to treat the keratoconus may actually require more invasive treatments to correct the vision loss. Keratoconus is progressive and will worsen in most young patients without treatment.
Therefore, do not wait to seek treatment! Early treatment will preserve your vision and lower the likelihood of needing a corneal transplant in the future.
Cornea Cross-Linking, an FDA approved treatment, is available to help prevent this condition from worsening. Cornea Cross-Linking is a simple, non-invasive treatment for keratoconus that can stabilize your cornea and halt the disease progression. Cornea Cross-Linking has had a very high success rate (99.3%) in preventing the need for corneal transplants and has been effective for thousands of patients around the globe. Dr. Ovette Villavicencio Participated for 2 years in the FDA studies for Cornea Cross-Linking.
Keratoconus Surgical Treatment Options
Cornea Cross-Linking (CXL) – A Minimally invasive outpatient procedure that strengthens the cornea that has been weakened by keratoconus. Treatment involves removing the outer skin covering of the cornea and applying riboflavin (Vitamin B) to the surface of the eye, followed by treatment with ultraviolet light. A bandage soft contact lens is placed after treatment to protect the eye until the surface heals. In 3-5 days the contact lens can be removed.
